Hims & Hers Health, Inc. (HIMS)
| Market Cap | 9.61B |
| Revenue (ttm) | 1.78B |
| Net Income (ttm) | 164.40M |
| Shares Out | 223.83M |
| EPS (ttm) | 0.68 |
| PE Ratio | 63.00 |
| Forward PE | 52.24 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 63,599,712 |
| Open | 42.44 |
| Previous Close | 41.98 |
| Day's Range | 41.84 - 44.38 |
| 52-Week Range | 13.47 - 72.98 |
| Beta | 2.10 |
| Analysts | Hold |
| Price Target | 38.00 (-11.53%) |
| Earnings Date | Aug 4, 2025 |
About HIMS
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supp... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for HIMS stock is "Hold." The 12-month stock price forecast is $38.0, which is a decrease of -11.53% from the latest price.
News
Hims & Hers: Here are the risks with the stock after Novo Nordisk terminated its partnership
Herb Greenberg, 'Herb on the Street' author, joins 'Power Lunch' to discuss Greenberg's thoughts on the terminated partnership between Novo Nordisk and Hims & Hers.
Johnson Fistel Investigates Hims & Hers Regulatory Evasion and Investor Impact
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding possible violations of fe...
HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?
Telehealth darling Hims & Hers Health Inc HIMS got slapped with a 34% stock crash on Monday. Novo Nordisk A/S NVO ended their relationship – and it wasn't amicable.
Hims & Hers: The Novo Nordisk Breakup Changes Nothing
The Novo Nordisk partnership ending does not alter my long-term bullish thesis on HIMS; the company is much more than just a GLP-1 play. HIMS' core value lies in its broad treatment offerings and disr...
Hims & Hers stock plummets after Novo Nordisk ends partnership over ‘knockoff' Wegovy
This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth company Hims & Hers Health (NYSE: HIMS), citing concerns over Hims & Hers' ...
HIMS INVESTIGATION NOTICE: Hims & Hers Health, Inc. is being Investigated for Securities Fraud– Investors are Notified to Contact BFA Law (NYSE:HIMS)
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential violations of the...
HIMS Stock To $25?
Hims & Hers Health (NASDAQ: HIMS) experienced a devastating 35% stock crash on June 23, 2025, after Novo Nordisk abruptly terminated their brief partnership. The dramatic sell-off reflects not just th...
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS
LOS ANGELES , June 23, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS)...
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation With the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $HIMS--HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm.
HIMS BREAKING NEWS: Hims & Hers Health, Inc. is being Investigated for Securities Fraud; Investors with Losses are Notified to Contact BFA Law
NEW YORK--(BUSINESS WIRE)---- $HIMS #Attorney--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential violations of ...
Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy, Faces Investor Scrutiny – Hagens Berman
SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares crash over 30% after Novo Nordisk announced that it t...
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – HIMS
LOS ANGELES--(BUSINESS WIRE)---- $HIMS--Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – HIMS.
Weight Loss Woes: Hims & Hers (HIMS) Shares Under Pressure
Hims & Hers (HIMS) shares are reeling after Novo Nordisk (NVO) severs its weight-loss drug relationship with the telehealth company. NVO claims HIMS was marketing knock-off weight loss drugs using "de...
US strikes Iran nuclear sites, Tesla shares rise, Hims & Hers falls
Here are some of the stories covered on Market Catalysts for Monday, June 23. Stocks wavered on news that the US bombed Iranian nuclear sites.
Novo Nordisk Ends Partnership with Hims & Hers
The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations about Hims' compounding and deceptive marketing practices.
Top Stock Movers Now: Tesla, Hims & Hers, Wolfspeed, and More
U.S. equities advanced at midday as oil prices declined on doubts the weekend U.S. military strikes against Iran and possible retaliation from Iran would disrupt supplies. The Dow Jones Industrial Ave...
Novo Nordisk under pressure, ends deal with Hims & Hers
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest details on the pharmaceutical space.
BREAKING: Hims & Hers Health, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
BOSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Hims & Hers Health, Inc. (NYSE: HIMS) for potential securities law violations. Investors who have lost money in their Hims & ...
HIMS Plummets, AMD Upgrade, DASH 3-Year High
Diane King Hall joins Nicole Petallides at the NYSE to focus on several early movers in Monday's trading session. Hims & Hers (HIMS) shares drop on news that Novo Nordisk (NVO) will no longer allow th...
Hims & Hers' stock plunges. Here's why Wegovy parent ended its partnership with the company.
Hims & Hers Health Inc.'s stock fell sharply on Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth-consultatio...
HIMS stock plunges as Novo Nordisk severs ties with Hims & Hers over Wegovy sales
Novo Nordisk A/S has abruptly terminated its partnership with Hims & Hers Health Inc., just weeks after it was announced, over concerns related to the telehealth company's sale and promotion of compou...
Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership
Novo Nordisk accuses the telehealth company of breaking a law related to drug compounding.
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Novo Nordisk said it is ending its collaboration with Hims & Hers due to concerns about the telehealth company's sales and promotion of cheaper knock-offs of the weight loss drug Wegovy. Novo Nordisk...
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
Collaboration of over one month has ended based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy ® that put patient safety at risk Novo Nordisk won't stop ta...
Novo Nordisk ends collaboration with Hims & Hers over weight loss drug sale
Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight loss drugs.